DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network.

Karlyn A Martin,Nicola Lancki,Lisa Baumann Kreuziger,Celina Li,M Elaine Eyster,Kristen Sanfilippo,Scott C Woller,Rachel P Rosovsky

Thrombosis research（2023）

引用 0|浏览15

暂无评分

摘要

•Limited data exist for use of DOACs for treatment of VTE in underweight patients.•We performed a multicenter retrospective study of DOACs vs warfarin in this population.•There was no difference in recurrent VTE between DOACs and warfarin in underweight patients.•There was no difference in major bleeding between DOACs and warfarin in underweight patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要